This inventor holds 1 USPTO granted patent. Top assignee: Institute of Nuclear Energy Research. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: Innovations in Tumor Imaging: The Contributions of Ming-Der Yu
Introduction
Ming-Der Yu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical imaging, particularly in the development of novel tumor imaging agents. His work has the potential to enhance the accuracy of tumor detection and treatment monitoring.
Latest Patents
Ming-Der Yu holds a patent for "Gallium dimercaptosuccinate as a novel tumor imaging agent." This innovative compound involves the dissolution of dimercaptosuccinic acid in phosphate buffer, which is then labeled with the radioisotope gallium. The gallium dimercaptosuccinate has been characterized through various experiments, including serum stability, biodistribution, and imaging experiments. The results confirm that this compound serves as a novel radiopharmaceutical for tumor imaging.
Career Highlights
Ming-Der Yu is affiliated with the Institute of Nuclear Energy Research, where he continues to advance research in nuclear medicine and imaging technologies. His work is pivotal in the development of new diagnostic tools that can improve patient outcomes.
Collaborations
Ming-Der Yu has collaborated with notable colleagues, including Zei-Tsan Tsai and Shyh-Yi Chyi. Their combined expertise contributes to the innovative research being conducted at the Institute of Nuclear Energy Research.
Conclusion
Ming-Der Yu's contributions to tumor imaging through his patented innovations highlight the importance of research in medical technology. His work not only advances scientific knowledge but also has the potential to significantly impact patient care in oncology.